| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | 218,3 k € | ||||||||||||||
| Gross margin | 184,6 k € | +6.4% | 173,6 k € | -8.2% | 189,0 k € | +22.5% | 154,3 k € | +14.9% | 134,3 k € | +18.9% | 112,9 k € | +12.9% | 100,0 k € | +14.2% | 87,6 k € | -6.0% | 93,1 k € | +50.6% | 61,8 k € | -24.7% | 82,1 k € | -0.7% | 82,6 k € | +15.7% | 71,4 k € | -40.1% | 119,1 k € | |
| EBITDA | 183,9 k € | +10.6% | 166,4 k € | -9.4% | 183,7 k € | +21.2% | 151,6 k € | +13.3% | 133,8 k € | +19.0% | 112,4 k € | +13.2% | 99,4 k € | +14.0% | 87,2 k € | -6.0% | 92,8 k € | +51.0% | 61,4 k € | -24.7% | 81,6 k € | -0.8% | 82,2 k € | +15.8% | 71,0 k € | -40.1% | 118,5 k € | |
| Operating profit | 180,0 k € | +20.5% | 149,4 k € | -10.4% | 166,7 k € | +22.8% | 135,7 k € | +13.6% | 119,5 k € | +22.2% | 97,8 k € | +0.3% | 97,4 k € | +44.2% | 67,6 k € | +22.1% | 55,3 k € | +203.8% | 18,2 k € | -44.8% | 33,0 k € | -2.5% | 33,8 k € | +48.9% | 22,7 k € | -50.0% | 45,4 k € | |
| Profit/loss | 122,2 k € | +22.0% | 100,1 k € | -10.5% | 111,9 k € | +20.2% | 93,1 k € | +15.7% | 80,5 k € | +23.2% | 65,3 k € | -3.3% | 67,6 k € | +73.2% | 39,0 k € | +18.2% | 33,0 k € | +262.4% | 9,1 k € | -53.7% | 19,7 k € | +3.0% | 19,1 k € | +36.9% | 14,0 k € | -53.7% | 30,1 k € | |
| Equity | 522,0 k € | +12.2% | 465,1 k € | +7.5% | 432,5 k € | +20.3% | 359,7 k € | +34.9% | 266,6 k € | +43.2% | 186,1 k € | +54.0% | 120,8 k € | +126.8% | 53,3 k € | +273.6% | 14,3 k € | -86.3% | 104,4 k € | +9.6% | 95,3 k € | +26.0% | 75,6 k € | +33.8% | 56,5 k € | +32.8% | 42,5 k € | |
| Total assets | 629,7 k € | -1.0% | 636,2 k € | +13.7% | 559,5 k € | +30.0% | 430,5 k € | +28.6% | 334,6 k € | +20.9% | 276,8 k € | +46.9% | 188,4 k € | +35.4% | 139,1 k € | -27.8% | 192,8 k € | +10.4% | 174,5 k € | -7.1% | 188,0 k € | -3.1% | 194,0 k € | -7.3% | 209,2 k € | -15.1% | 246,4 k € | |
| Cash | 41,0 k € | -30.8% | 59,2 k € | -18.8% | 73,0 k € | +106.9% | 35,3 k € | -29.7% | 50,2 k € | +718.8% | 6,1 k € | — | 5,8 k € | -50.0% | 11,6 k € | — | 3,1 k € | -76.2% | 12,9 k € | +40.4% | 9,2 k € | +30.4% | 7,0 k € | |||||
| Debts | 107,7 k € | -37.0% | 171,1 k € | +34.8% | 126,9 k € | +79.2% | 70,8 k € | +4.1% | 68,0 k € | -24.9% | 90,7 k € | +34.2% | 67,6 k € | -21.3% | 85,8 k € | -51.9% | 178,5 k € | +154.5% | 70,1 k € | -24.3% | 92,7 k € | -21.7% | 118,4 k € | -22.5% | 152,7 k € | -25.1% | 203,9 k € | |
Private limited company · Soignies · incorporated on 28/01/2011
Private limited company profitable and well capitalised. Cash position declining (-30.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOCTEUR SALVATORE LO BUE is a Private limited company incorporated in 2011. Its main activity is: Other human health activities. Its registered office is in Soignies.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.